|
Name |
Cytochalasin Z13
|
Molecular Formula | C25H33NO5 | |
IUPAC Name* |
(3S,3aS,6S,7S,7aS)-3-benzyl-6,7a-dihydroxy-7-[(E,4S,6S)-6-hydroxy-4-methyl-5-oxohept-1-enyl]-4,5-dimethyl-3,3a,6,7-tetrahydro-2H-isoindol-1-one
|
|
SMILES |
CC1=C([C@H]([C@@H]([C@]2([C@@H]1[C@@H](NC2=O)CC3=CC=CC=C3)O)/C=C/C[C@H](C)C(=O)[C@H](C)O)O)C
|
|
InChI |
InChI=1S/C25H33NO5/c1-14(22(28)17(4)27)9-8-12-19-23(29)16(3)15(2)21-20(26-24(30)25(19,21)31)13-18-10-6-5-7-11-18/h5-8,10-12,14,17,19-21,23,27,29,31H,9,13H2,1-4H3,(H,26,30)/b12-8+/t14-,17-,19-,20-,21-,23+,25+/m0/s1
|
|
InChIKey |
DCWOIJNXHXDCKT-YJFGZGKKSA-N
|
|
Synonyms |
Cytochalasin Z13; CHEMBL458323
|
|
CAS | NA | |
PubChem CID | 24970397 | |
ChEMBL ID | CHEMBL458323 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 427.5 | ALogp: | 1.2 |
HBD: | 4 | HBA: | 5 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 107.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 31 | QED Weighted: | 0.501 |
Caco-2 Permeability: | -5.185 | MDCK Permeability: | 0.00006020 |
Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.988 |
Human Intestinal Absorption (HIA): | 0.047 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.734 | Plasma Protein Binding (PPB): | 97.08% |
Volume Distribution (VD): | 1.452 | Fu: | 3.70% |
CYP1A2-inhibitor: | 0.038 | CYP1A2-substrate: | 0.122 |
CYP2C19-inhibitor: | 0.098 | CYP2C19-substrate: | 0.743 |
CYP2C9-inhibitor: | 0.038 | CYP2C9-substrate: | 0.121 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.45 |
CYP3A4-inhibitor: | 0.144 | CYP3A4-substrate: | 0.359 |
Clearance (CL): | 8.967 | Half-life (T1/2): | 0.093 |
hERG Blockers: | 0.025 | Human Hepatotoxicity (H-HT): | 0.663 |
Drug-inuced Liver Injury (DILI): | 0.337 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.82 | Maximum Recommended Daily Dose: | 0.568 |
Skin Sensitization: | 0.254 | Carcinogencity: | 0.124 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.977 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003169 | 0.446 | D0C6NM | 0.305 | ||||
ENC002763 | 0.441 | D0RA5Q | 0.288 | ||||
ENC002174 | 0.435 | D0Q2XF | 0.280 | ||||
ENC004463 | 0.434 | D0A8XN | 0.269 | ||||
ENC004368 | 0.430 | D0R1BD | 0.267 | ||||
ENC005129 | 0.430 | D06PSS | 0.265 | ||||
ENC005130 | 0.430 | D06IXT | 0.262 | ||||
ENC003335 | 0.424 | D0QQ6Q | 0.258 | ||||
ENC003619 | 0.424 | D07HOF | 0.256 | ||||
ENC005174 | 0.424 | D0W7RJ | 0.256 |